Europe Cardiac Assist Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Europe Cardiac Assist Devices Market is Segmented by Product (Intra-aortic Balloon Pump, Total Artificial Heart, and Ventricular Assist Device),and Geography

Market Snapshot

Mar_summary_pro
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 7.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Certain factors that are driving the European cardiac assist devices market growth include increasing heart disease prevalence, the aging population, advancements in technology, and shortage of heart donors in transplantation. The continuous rapid advancements in the assist devices technologies and the novel applications of the existing treatments have led to an increase in cardiac assist devices. Engineers are also exploring many other innovative solutions, which help in implantation success, and is driving the cardiac assist devices market. Hence, the market is dependent upon a large number of innovations for growth. However, cardiac assist devices are highly expensive. The high costs of the devices and the low per capita income is likely to impede the market of cardiac assist devices in Europe. Other factors, such as the availability of alternative treatments, like pacemakers, and the risks associated with device implantation are also hindering the market growth.

Scope of the Report

As per the scope of the report, the assist devices are defined as a type of mechanical pump that works along with the heart to improve the pumping efficiency and maintain optimum blood flow throughout the body. Cardiac-assist devices are used to treat end-stage heart failure and are determined by the needs of the individual.

Product
Intra-aortic Balloon Pumps
Total Artificial Heart
Ventricular Assist Devices
Left Ventricular Assist Devices
Right Ventricular Assist Devices
Geography
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Total Artificial Heart Segment is Expected to Hold Significant Market Share

The various extracorporeal and ventricular assist devices can only be considered as temporary solutions. The only available option is a total artificial heart. It is considered as the best long-term solution for patients suffering from advanced heart failure issues.

There are, currently, many different types of artificial hearts in the market that are being used, like the SynCardia temporary total artificial heart, Abiocar replacement heart, and Carmat artificial heart, helping the market growth in the region. In December 2018, CARMAT the designer and developer of the world’s most advanced total artificial heart and European Investment Bank (EIB), which is the bank of the European Union (EU), entered into a EUR 30 million loan agreement supported by the European Fund for Strategic Investments (EFSI) for the marketing process of its total artificial heart in European countries.

Picture1_Europe Geriatric.png

Competitive Landscape

The European cardiac assist devices market is highly competitive and consists of a number of major players. Companies, like Abiomed, Berlin Heart, CardiacAssist Inc., Cardiobridge GmbH, Carmat, HeartWare, Jarvik Heart Inc., Xenios AG, MiTiHeart Corporation, SynCardia Systems LLC, among others, hold a substantial market share in the European cardiac assist devices market.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Heart Disease Prevalence

      2. 4.2.2 Advancements in Technology

    3. 4.3 Market Restraints

      1. 4.3.1 Expensive Instrument and Maintenance Issues

      2. 4.3.2 Risk Associated with Device Implantation

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Product

      1. 5.1.1 Intra-aortic Balloon Pumps

      2. 5.1.2 Total Artificial Heart

      3. 5.1.3 Ventricular Assist Devices

        1. 5.1.3.1 Left Ventricular Assist Devices

        2. 5.1.3.2 Right Ventricular Assist Devices

    2. 5.2 Geography

      1. 5.2.1 Europe

        1. 5.2.1.1 Germany

        2. 5.2.1.2 United Kingdom

        3. 5.2.1.3 France

        4. 5.2.1.4 Italy

        5. 5.2.1.5 Spain

        6. 5.2.1.6 Rest of Europe

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abiomed

      2. 6.1.2 Berlin Heart

      3. 6.1.3 CardiacAssist Inc.

      4. 6.1.4 Cardiobridge GmbH

      5. 6.1.5 Carmat

      6. 6.1.6 HeartWare

      7. 6.1.7 Jarvik Heart Inc.

      8. 6.1.8 Xenios AG

      9. 6.1.9 MiTiHeart Corporation

      10. 6.1.10 SynCardia Systems LLC

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Europe Cardiac Assist Devices Market market is studied from 2018 - 2026.

The Europe Cardiac Assist Devices Market is growing at a CAGR of 7.6% over the next 5 years.

Abiomed, Cardiobridge GmbH, Carmat, Berlin Heart, CardiacAssist Inc. (Tandem Life) are the major companies operating in Europe Cardiac Assist Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!